Costs of cancer care in the USA: A descriptive review

Nature Clinical Practice Oncology

Volumn 4, Issue 11, 2007, Pages 643-656

  Yabroff, K Robin ^a   Warren, Joan L ^a   Brown, Martin L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BREAST CANCER; BREAST SURGERY; CANCER; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURVIVAL; COLORECTAL CANCER; DESCRIPTIVE RESEARCH; DRUG COST; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; LONG TERM CARE; LUNG CANCER; MASTECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVIEW; UNITED STATES;

COSTS AND COST ANALYSIS; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HUMANS; INSURANCE, HEALTH; NEOPLASMS; UNITED STATES;

EID: 35648999978     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0978     Document Type: Review

References (79)

1. Ries LA et al. (2005) SEER Cancer Statistic Review, 1975-2002 National Cancer Institute: Bethesda MD
2. Brown ML and Yabroff KR (2006) Economic impact of cancer in the United States. In: Cancer Epidemiology and Prevention 202-214 (Eds Schottenfeld D and Faumeni JF) New York, NY., Oxford University Press
3. National Cancer Institute, NIH, DHHS (2007) Cancer Trends Progress Report - 2005 Update. Bethesda, MD: National Cancer Institute
4. Brown ML et al. (2002) Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care 40 (8 Suppl 104-117
5. Elixhauser A and Halpern MT (1999) Economic evaluations of gastric and pancreatic cancer. Hepatogastroenterology 46: 1206-1213
6. Goodwin PJ and Shepherd FA (1998) Economic issues in lung cancer: A review. J Clin Oncol 16:3900-3912
7. Ruchlin HS and Pellissier JM (2001) An economic overview of prostate carcinoma. Cancer 92: 2796-2810
8. Taplin SH et al. (1995) Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst 87: 417-426
9. Penberthy L et al. (1999) Predictors of Medicare costs in elderly beneficiaries with breast, colorectal, lung, or prostate cancer. Health Care Manag Sci 2: 149-160
10. Thorpe KE and Howard D (2003) Health insurance and spending among cancer patients. Health Aff (Millwood) (Suppl Web Exclusive): W3-189-W3-198
11. Langa KM et al. (2004) Out-of-pocket health care expenditures among older Americans with cancer. Value Health 7: 186-194
12. Polednak AP and Shevchenko IP (1998) Hospital charges for terminal care of cancer patients dying before age 65. Health Care Financ Rev 25: 26-34
13. Fireman BH et al. (1997) Cost of care for cancer in a health maintenance organization. Health Care Financ Rev 18: 51-76
14. Howard DH et al. (2004) National estimates of medical costs incurred,by nonelderly cancer patients. Cancer 100: 883-891
15. Chang S et al. (2004) Estimating the cost of cancer: Results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol 22: 3524-3530
16. Mullins CD et al. (2004) Economic disparities in treatment costs among ambulatory Medicaid cancer patients. J Natl Med Assoc 96 1565-1574
17. Warren JL et al. (2001) Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings. J Clin Oncol 20: 307-316
18. Given C et al. (2001) Observation interval for evaluating the costs of surgical interventions for older women with a new diagnosis of breast cancer. Med Care 39: 1146-1157
19. Oestreicher N et al. (2005) The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma. Cancer 104: 2054-2062
20. Barlow WE et al. (2001) Cost comparison of mastectomy versus breast-conserving therapy for early stage breast cancer. J Natl Cancer Inst 93: 447-455
21. Tollestrup K et al. (2001) The excess cost of breast cancer health care in Hispanic and non-Hispanic female members of a managed care organizatoin. Breast Cancer Res Treat 66: 25-31
22. Sasser AC et al. (2005) Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population. Women's Health Issues 15: 97-108
23. Rao S et al. (2004) Cost of illness associated with metastatic breast cancer. Breast Cancer Res Treat 83: 25-32
24. Arozullah AM et al. (2004) The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol 2: 271-278
25. Brown ML et al. (1999) Obtaining long-term disease specific costs of care: Application to Medicare enrollees diagnosed with colorectal cancer. Med Care 37:1249-1259
26. Ramsey SD et al. (2002) Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer. Am J Gastroenterol 97: 440-445
27. Etzioni R et al. (2001) The impact of including future medical care costs when estimating the costs attributable to disease: A colorectal cancer case study. Health Econ 10: 245-256
28. Kerrigan M et al. (2005) Costs and survival of patients with colorectal cancer in a health maintenance organization and a preferred provider organization. Med Care 43: 1043-1048
29. Seifeldin R and Hantsch JJ (1999) The economic burden associated with colon cancer in the United States. Clin Ther 21: 1370-1379
30. Ramsey SD et al. (2004) Chemotherapy use, outcomes, and costs for older persons with advanced non-small cell lung cancer: Evidence from Surveillance, Epidemiology and End Results-Medicare. J Clin Oncol 22: 4971-4978
31. Hillner BE et al. (1998) Posts of care associated with non-small-cell lung cancer in a commercially insured cohort. J Clin Oncol 16: 1420-1424
32. Kutikova L et al. (2005) The economic burden of lung cancer and the associated costs of treatment failure. Lung Cancer 50: 143-154
33. Hoverman JR and Roberston SM (2004) Lung cancer: A cost and outcome study based on physician practice patterns. Dis Manag 7 112-123
34. Burkhardt JH et al. (2002) Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early-stage prostate cancer. J Clin Oncol 20: 2869-2875
35. Penson DF et al. (2004) The economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer. findings from a retrospective analysis of health plan data. J Urol 171: 2250-2254
36. Brandeis J et al. (2000) A nationwide charge comparison of the principal treatments for early stage prostate carcinoma. Cancer 89: 1792-1799
37. Max W et al. (2002) The economic burden of prostate cancer, California, 1998. Cancer 94: 2906-2913
38. Kramolowsky EV et al. (1995) The role of the physician in effecting change in hospital charge for radical prostatectomy. J Am Coll Surg 180: 513-518
39. Jayadevappa R et al. (2005) Medical care costs of patients with prostate cancer. Urol Oncol 23: 155-162
40. Dimick JB et al. (2006) Hospital volume is related to clinical and economic outcomes of esophageal resection in Maryland. Ann Thorac Surg 72: 334-341
41. Rizzo JD et al. (1999) Outpatient-based bone marrow transplantation for hematologic malignancies: Cost saving or cost shifting? J Clin Oncol 17: 2811-2818
42. Etzioni R et al. (1996) Estimating the costs attributable to a disease with application to ovarian cancer. J Clin Epidemiol 49 95-103
43. Chang S et al. (2006) Burden of pancreatic cancer and disease progression; economic analysis in the US. Oncology 70: 71-80
44. Green DM et al. (1998) Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 16: 3744-3751
45. Ramsey SD et al. (2002) Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer. J Natl Cancer Inst 94: 291-297
46. Hensley ML et al. (2005) Economic outcomes of breast cancer survivorship: CALGB study 79804. Breast Cancer Res Treat 91: 153-161
47. Ritz LJ et al. (2000) Effects of advanced nursing care on quality of life and cost outcomes of women diagnosed with breast cancer. Oncol Nurs Forum 27:923-932
48. Brown ML et al. (2001) The burden of illness in cancer: Economic cost and quality of life. Ann Rev Public Health 22:91-113
49. Dickersin K et al. (1994) Identifying relevant studies for systematic reviews. BMJ 309: 1286-1291
50. Ray GT et al. (2000) The cost of health conditions in a health maintenance organization. Med Care Res Rev 57:92-109
51. Fishman P et al. (1997) Chronic care costs in managed care. Health Aff (Millwood) 16: 239-247
52. Riley GF et al. (1995) Medicare payments from diagnosis to death for elderly cancer patients by stage and diagnosis. Med Care 33 828-841
53. Desch CE et al. (1999) A sociodemographic and economic comparison of breast reconstruction, mastectomy, and conservative surgery. Surgery 125: 441-447
54. Legorreta AP et al. (1996) Cost of breast cancer treatment: A 4-year longitudinal study. Arch Intern Med 156: 2197-2201
55. Lamerato L et al. (2006) Economic burden associated with breast cancer recurrence: Findings from a retrospective analysis of health system data. Cancer 106: 1875-1882
56. Polednak AP et al. (1996) Estimating breast cancer treatment charges in Connecticut. Conn Med 60: 263-267
57. Ramsey SD et al. (2003) Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer. Gastroenterology 125: 1645-1650
58. Paramore LC ett al. (2006) Estimating costs of care for patients with newly diagnosed metastatic colorectal cancer. Clin Colorectal Cancer 6: 52-58
59. Au DH et al. (2006) Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med 166: 326-331
60. Penson DF et al. (2001) Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: Results from the CaPSURE database. Urology 57: 499-503
61. Litwin MS et al. (1998) Epidemiological trends and financial outcomes in radical prostatectomy among Medicare beneficiaries, 1991 to 1993. J Urology 160: 445-448
62. Benoit RM et al. (1998) Comparison of the hospital costs for radical prostatectomy and cryosurgical ablation of the prostate. Urology 52: 820-824
63. Lang K et al. (2004) The economic cost of squamous cell cancer of the head and neck. Arch Otolaryngol Head Neck Surg 130: 1269-1275
64. Du W et al. (2000) Cost analysis of pancreatic carcinoma treatment. Cancer 89: 1917-1924
65. Max W et al. (2003) The economic burden of gynecologic cancers in California, 1998. Gynecol Oncol 88: 96-103
66. Hillner BE et al. (2001) Burden of illness associated with metastatic melanoma: An audit of 100 consecutive referral center cases. Cancer 91: 1814-1821
67. Menzin J et al. (2004) Treatment patterns, outcomes and costs among elderly patients with chronic myeloid leukaemia: A population-based analysis. Drugs Aging 21: 737-746
68. Menzin J et al. (2002) The outcomes and costs of acute myeloid leukemia among the elderly. Arch Intern Med 162: 1597-1603
69. Bennett CL et al. (1995) Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991. J Clin Oncol 13: 969-973
70. Finkler SA (1982) The distinction between cost and charges. Ann intern Med 96: 102-109
71. Mandelblatt J et al. (2004) Descriptive review of the literature on breast cancer outcomes: 1990 through 2000. J Natl Cancer Inst Monogr 33: 8-44
72. Yabroff KR et al. (2007) Patient time costs associated with cancer care. J Natl Cancer Inst 99: 14-23
73. Hayman JA et al. (2001) Estimating the cost of informal caregiving for elderly patients with cancer. J Clin Oncol 19: 3219-3225
74. Bradley CJ et al. (2005) Employment outcomes of men treated for prostate cancer. J Natl Cancer Inst 97: 958-965
75. Bach PB et al. (2004) Resurrecting treatment histories of dead patients: A study design that should be laid to rest. JAMA 292 2765-2770
76. Schrag D (2004) The price tag on progress-chemotherapy for colorectal cancer. N Engl J Med 351: 317-319
77. Warren JL et al. (1999) Use of Medicare hospital and physician data to assess breast cancer incidence. Med Care 37: 445-456
78. Freeman JL et al. (2000) An approach to identifying incident breast cancer cases using Medicare claims data. J Clin Epidemiol 53: 605-614
79. Gold MR et al. (Eds) (1996) Cost-effectiveness in Health and Medicine. New York: Oxford University. Press